Bukten Anne, Lund Ingunn Olea, Kinner Stuart A, Rognli Eline Borger, Havnes Ingrid Amalia, Muller Ashley Elizabeth, Stavseth Marianne Riksheim
Norwegian Centre for Addiction Research, University of Oslo, Kirkveien 166, 0407, Oslo, Norway.
Section for Clinical Addiction Research, Oslo University Hospital, Oslo, Norway.
Health Justice. 2020 May 12;8(1):10. doi: 10.1186/s40352-020-00112-8.
Remarkably little is known about drug use during imprisonment, including whether it represents a continuation of pre-incarceration drug use, or whether prison is also a setting for drug use initiation. This paper aims to describe drug use among people in prison in Norway and investigate risk factors associated with in-prison drug use.
We used data from the Norwegian Offender Mental Health and Addiction (NorMA) Study, a cross-sectional survey of 1499 individuals in Norwegian prisons. Respondents reported on drug use (narcotics and non-prescribed medications) both before and during imprisonment. We used multivariate logistic regression to investigate the associations between drug use in prison and demographics, previous drug use, mental health, and criminal activity.
Sixty-five percent of respondents reported lifetime drug use, and about 50% reported daily use of drugs during the 6 months before incarceration. Thirty-five percent reported ever using drugs in prison, but initiation of drug used during incarceration was uncommon. In a multivariate model, factors independently associated with drug use in prison included lifetime number of drugs used (adjusted odds ratio [aOR] = 1.17; 95% confidence interval [CI] 1.12-1.23; p < 0.001), daily drug use in the 6 months before imprisonment (aOR = 7.12; 95%CI 3.99-12.70; p < 0.001), and being intoxicated while committing the crime related to current imprisonment (aOR = 2.13; 95%CI 1.13-4.03; p = 0.020).
In-prison drug use is independently associated with high-risk drug use before imprisonment. To reduce drug use in prison, correctional services must systematically screen for pre-prison drug use and offer effective drug treatment for those in need.
人们对监禁期间的药物使用情况知之甚少,包括这是监禁前药物使用的延续,还是监狱也是药物使用开始的场所。本文旨在描述挪威监狱中人员的药物使用情况,并调查与监狱内药物使用相关的风险因素。
我们使用了挪威罪犯心理健康与成瘾(NorMA)研究的数据,这是一项对挪威监狱中1499名个体的横断面调查。受访者报告了监禁前后的药物使用情况(麻醉药品和非处方药物)。我们使用多变量逻辑回归来研究监狱内药物使用与人口统计学、既往药物使用、心理健康和犯罪活动之间的关联。
65%的受访者报告有终生药物使用史,约50%的受访者报告在入狱前6个月内每天使用药物。35%的受访者报告曾在监狱中使用过药物,但在监禁期间开始使用药物的情况并不常见。在多变量模型中,与监狱内药物使用独立相关的因素包括终生使用药物的种类数量(调整后的优势比[aOR]=1.17;95%置信区间[CI]1.12-1.23;p<0.001)、入狱前6个月内每天使用药物(aOR=7.12;95%CI 3.99-12.70;p<0.001)以及在实施与当前监禁相关的犯罪时处于醉酒状态(aOR=2.13;95%CI 1.13-4.03;p=0.020)。
监狱内药物使用与入狱前的高风险药物使用独立相关。为减少监狱内的药物使用,惩教服务部门必须系统地筛查入狱前的药物使用情况,并为有需要的人提供有效的药物治疗。